Factor X deficiency

被引:137
作者
Uprichard, J
Perry, DJ
机构
[1] Royal Free Hosp, Haemophilia Ctr, London NW3 2QG, England
[2] Royal Free Hosp, Haemostasis Unit, London NW3 2QG, England
关键词
factor X; deficiency; gene; mutation; treatment; acquired;
D O I
10.1054/blre.2002.0191
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Factor X is one of the vitamin K-dependent serine proteases. It plays a crucial role in the coagulation cascade, as the first enzyme in the common pathway of thrombus formation. The gene for factor X maps to the long arm of chromosome 13, approximately 2.8 kb downstream of the factor VII gene. The gene consists of eight exons, each of which encodes a specific functional domain within the protein. Both the gene structure and the amino acid sequence show homology to other vitamin K-dependent clotting factors, suggesting their origin in a common ancestral protein. Factor X deficiency is one of the rarest of the inherited coagulation disorders. Inheritance is in an autosomal recessive manner. The clinical phenotype is of a variable bleeding tendency. Homozygous factor X deficiency has an incidence of 1: 1, 000, 000 in the general population. Heterozygotes are often clinically asymptomatic. Acquired factor X deficiency is rare, but when it occurs it is usually in association with amyloidosis. Treatment of factor X deficiency involves replacement of the protein with either fresh frozen plasma or prothrombin complex concentrates, although the latter should be used with caution as infusion may be associated with an increased risk of thrombosis. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:97 / 110
页数:14
相关论文
共 118 条
  • [1] BAJAJ SP, 1973, J BIOL CHEM, V248, P7729
  • [2] Beardell FV, 1997, AM J HEMATOL, V54, P68, DOI 10.1002/(SICI)1096-8652(199701)54:1<68::AID-AJH10>3.0.CO
  • [3] 2-6
  • [4] BERECZKY Z, 2001, J THROMBOSIS H S JUL
  • [5] TOPOLOGICALLY EQUIVALENT MUTATIONS CAUSING DYSFUNCTIONAL COAGULATION-FACTORS-VII ((294)ALA-]VAL) AND X((334)SER-]PRO)
    BERNARDI, F
    CASTAMAN, G
    REDAELLI, R
    PINOTTI, M
    LUNGHI, B
    RODEGHIERO, F
    MARCHETTI, G
    [J]. HUMAN MOLECULAR GENETICS, 1994, 3 (07) : 1175 - 1177
  • [6] BERNARDI F, 1989, BLOOD, V73, P2123
  • [7] Recombinant human factor VIIa in the management of amyloid-associated factor X deficiency
    Boggio, L
    Green, D
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2001, 112 (04) : 1074 - 1075
  • [8] THE CONTRIBUTIONS OF CA-2+, PHOSPHOLIPIDS AND TISSUE-FACTOR APOPROTEIN TO THE ACTIVATION OF HUMAN BLOOD-COAGULATION FACTOR-X BY ACTIVATED FACTOR-VII
    BOM, VJJ
    BERTINA, RM
    [J]. BIOCHEMICAL JOURNAL, 1990, 265 (02) : 327 - 336
  • [9] ACQUIRED SELECTIVE FACTOR-X DEFICIENCY IN ACUTE NONLYMPHOCYTIC LEUKEMIA
    CAIMI, MT
    REDAELLI, R
    CATTANEO, D
    NOSARI, AM
    BAUDO, F
    DECATALDO, F
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 1991, 36 (01) : 65 - 66
  • [10] CAMIRE RM, 2001, J THROMBOSIS H S JUL